SIS Medical AG Welcomes the Results of the VICTORY Trial Demonstrating Non-inferiority of OPN NC to Intravascular Lithotrispy (IVL) for Lesion Preparation and Stent Expansion in Severely Calcified Lesions

Contributed by: Business Wire

Logo

Business Wire logo

Images

"With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland
"With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland
Business Wire embedded0

Tags

Medical Devices
Health
Surgery
Clinical Trials
Cardiology
Biotechnology
SIS Medical AG

More Like This

PR Newswire associated0

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

PR Newswire associated0

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

PR Newswire associated0

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

PR Newswire associated0

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

PR Newswire associated0

FLEX Vessel Prep™ System FLEX FIRST AV Registry 6-Month Data and the Hamburg Vessel Prep Experience Prior to Angioplasty presented at Charing Cross Symposium

PR Newswire associated0

SIRPAD - WORLD'S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT

PR Newswire associated0

Meril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025